Privia Health Group, Inc.
PRVA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $1 | $1 |
| % Growth | 4.7% | 22.2% | 40.4% | – |
| Cost of Goods Sold | $2 | $1 | $1 | $1 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 10.2% | 9.7% | 9.9% | 6.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | -$0 | -$0 |
| % Margin | 1% | 1.2% | -1.4% | -22.5% |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | $0 | $0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | -$0 | -$0 |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 0.8% | 1.4% | -0.6% | -19.5% |
| EPS | 0.12 | 0.2 | -0.11 | -1.77 |
| % Growth | -40% | 281.8% | 93.8% | – |
| EPS Diluted | 0.11 | 0.19 | -0.11 | -1.77 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 1.4% | 1.6% | -1.1% | -22.2% |